APC and neoplasm: The accumulation and aberrant activation of β-catenin signaling, as well as the transcription of target genes (hypothesized to contribute to various stages in tumor development) result from mutations in the adenomatous polyposis coli protein that abolish its capacity to bind β-catenin or mutations in the β-catenin phosphorylation motif at the N-terminus.